Current News

	Search for:		in:

Target:

Full text

Title

Company name

Division:

Country:

From:

To:

Operation:		OR		AND
Search for:		partial		exact

Overview

Companies

Countries

BioMS Medical receives additional patent for multiple sclerosis drug MBP8298 in the United States

06 Nov 2006 - BioMS Medical Corp announced that the University of Alberta has received additional patents for the Company's synthetic peptide therapeutic, MBP8298, for the treatment of multiple sclerosis (MS). BioMS Medical licenses these patents on an exclusive worldwide basis from the University of Alberta.

�
The most recent patent, entitled "Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient" has been granted in the United States and addresses methods of predicting efficacy of certain courses of treatment for MS patients.

�

Additional information

BioMS Medical Corp.
Edmonton, Alberta, Canada

Company

Buyer's Guide entry of BioMS Medical Corp.

�

News

	24 Sep 2008 -	BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
	15 Aug 2008 -	BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
	05 Aug 2008 -	BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
�more news

University of Alberta
Edmonton, Canada

News

	31 Jan 2008 -	Lab on a chip developed at University of Alberta for cheap, portable medical tests
	26 Jan 2007 -	Alberta researchers 1st to complete the human metabolome
	28 Apr 2006 -	Geron announces issuance of US patent for production of insulin secreting cells from human embryonic stem cells
�more news